US Stock MarketDetailed Quotes
CRMD CorMedix
- 12.470
- +0.120+0.97%
Close Oct 24 16:00 ET
- 12.570
- +0.100+0.80%
Post 20:01 ET
720.28MMarket Cap-13554P/E (TTM)
12.670High11.600Low1.89MVolume12.370Open12.350Pre Close23.04MTurnover3.30%Turnover RatioLossP/E (Static)57.76MShares12.67052wk High15.59P/B713.16MFloat Cap2.57052wk Low--Dividend TTM57.19MShs Float52.000Historical High--Div YieldTTM8.66%Amplitude0.729Historical Low12.196Avg Price1Lot Size
CorMedix Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -63.78%-14.04M | -66.54%-17.31M | -57.70%-38.41M | -74.59%-10.75M | -45.07%-8.7M | -56.94%-8.57M | -54.11%-10.39M | -15.13%-24.36M | -4.86%-6.15M | -8.94%-6M |
| Net income from continuing operations | -25.53%-14.15M | -36.90%-14.47M | -56.02%-46.34M | -79.73%-14.75M | -42.18%-9.74M | -48.24%-11.27M | -50.23%-10.57M | -5.29%-29.7M | -5.36%-8.21M | 20.02%-6.85M |
| Depreciation and amortization | 341.06%76.87K | 29.43%21.83K | -16.38%70.76K | -17.08%18.67K | -16.40%17.79K | -15.26%17.43K | -16.73%16.86K | 36.72%84.62K | 12.32%22.52K | 21.16%21.28K |
| Other non cash items | 9.45%36.47K | 9.40%35.64K | 8.35%134.81K | 9.34%34.84K | 9.28%34.07K | 7.39%33.32K | 7.33%32.58K | 8.07%124.42K | 7.27%31.86K | 7.21%31.18K |
| Change In working capital | -179.44%-1.27M | -155.48%-5.35M | 109.15%2.23M | 143.19%2.74M | 95.60%-7.81K | 56.58%1.59M | -132.74%-2.09M | -41.90%1.07M | 81.96%1.13M | -109.01%-177.7K |
| -Change in receivables | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 195.61%42.14K | 99.07%-440 | -136.07%-1.16K |
| -Change in inventory | ---1.69M | ---214.05K | -70,124.77%-2.11M | -783,127.88%-2.11M | --0 | --0 | --0 | -97.93%3.01K | -99.41%269 | -93.91%1.45K |
| -Change in prepaid assets | 16.49%-904.13K | -192.31%-1.23M | -420.98%-600.98K | 1,463.83%1.16M | -500.53%-253.93K | -1,705.52%-1.08M | -397.35%-419.58K | -71.91%187.24K | -116.42%-84.7K | 155.46%63.4K |
| -Change in payables and accrued expense | -41.93%1.57M | -135.85%-3.87M | 430.94%5.07M | 199.82%3.72M | 232.63%280.02K | 177.15%2.71M | -55.79%-1.64M | -18.79%955.4K | 835.22%1.24M | -110.12%-211.14K |
| -Change in other current liabilities | -11.79%-37.07K | -11.79%-36.24K | -11.07%-134.8K | -11.84%-35.32K | -12.08%-33.91K | -10.14%-33.16K | -10.15%-32.42K | -11.31%-121.37K | -10.19%-31.58K | -10.43%-30.25K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -63.78%-14.04M | -66.54%-17.31M | -57.70%-38.41M | -74.59%-10.75M | -45.07%-8.7M | -56.94%-8.57M | -54.11%-10.39M | -15.13%-24.36M | -4.86%-6.15M | -8.94%-6M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 362.74%6.27M | 160.90%8.94M | -359.96%-17.06M | 32,222.08%597.79K | -413.52%-586.87K | -501.35%-2.39M | -250.72%-14.69M | 59.39%-3.71M | 99.97%-1.86K | 91.01%-114.28K |
| Net PPE purchase and sale | -447.17%-34.79K | -315.18%-61.31K | -49.21%-327.3K | -129.84%-295.93K | 86.59%-10.25K | 35.54%-6.36K | -241.49%-14.77K | 84.61%-219.36K | 79.52%-128.76K | 90.18%-76.42K |
| Net investment purchase and sale | 364.91%6.3M | 161.38%9.01M | -379.49%-16.73M | 604.31%893.72K | -1,422.83%-576.62K | -493.75%-2.38M | -250.73%-14.67M | 54.73%-3.49M | 101.95%126.89K | 92.33%-37.87K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 362.74%6.27M | 160.90%8.94M | -359.96%-17.06M | 32,222.08%597.79K | -413.52%-586.87K | -501.35%-2.39M | -250.72%-14.69M | 59.39%-3.71M | 99.97%-1.86K | 91.01%-114.28K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -80.25%1.06M | -101.35%-97.12K | 212.42%55.92M | -92.26%467.65K | 9,710.09%42.9M | -36.39%5.35M | 139.68%7.2M | -57.14%17.9M | 6.05M | 437.29K |
| Net common stock issuance | -81.00%1.01M | --0 | 214.17%55.83M | -92.82%433.9K | 13,791.56%42.88M | -36.81%5.31M | 139.68%7.2M | -57.14%17.77M | --6.05M | --308.67K |
| Proceeds from stock option exercised by employees | ---- | ---- | 123.70%287.74K | --33.75K | -84.35%20.13K | ---- | ---- | -57.40%128.63K | --0 | --128.63K |
| Net other financing activities | ---139.5K | ---97.12K | ---198.44K | ---1 | --0 | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -80.25%1.06M | -101.35%-97.12K | 212.42%55.92M | -92.26%467.65K | 9,710.09%42.9M | -36.39%5.35M | 139.68%7.2M | -57.14%17.9M | --6.05M | --437.29K |
| Net cash flow | ||||||||||
| Beginning cash position | 38.68%35.36M | 1.03%43.82M | -19.00%43.37M | 23.08%53.5M | -59.54%19.89M | -44.11%25.5M | -19.00%43.37M | 27.21%53.55M | -34.68%43.47M | -32.97%49.15M |
| Current changes in cash | -19.73%-6.71M | 52.67%-8.46M | 104.38%445.64K | -8,611.45%-9.68M | 692.59%33.61M | -258.26%-5.61M | -125.54%-17.88M | -188.67%-10.17M | 99.15%-111.12K | 16.27%-5.67M |
| Effect of exchange rate changes | -135.63%-88 | -135.25%-805 | 132.36%2.81K | -84.65%2.42K | 80.33%-2.15K | 102.38%247 | 171.85%2.28K | 32.84%-8.68K | 605.99%15.79K | -105.87%-10.91K |
| End cash Position | 44.02%28.65M | 38.68%35.36M | 1.03%43.82M | 1.03%43.82M | 23.08%53.5M | -59.54%19.89M | -44.11%25.5M | -19.00%43.37M | -19.00%43.37M | -34.68%43.47M |
| Free cash flow | -64.06%-14.07M | -66.90%-17.37M | -57.62%-38.74M | -75.72%-11.04M | -43.41%-8.71M | -56.78%-8.58M | -54.23%-10.41M | -8.84%-24.58M | 3.30%-6.28M | 3.34%-6.07M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data